Nearly half of all Americans have high blood pressure – a condition called hypertension. Hypertension is the No. 1 risk ...

For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to a ...

The new drug Baxdrostat lowers resistant hypertension in difficult-to-treat patients, showing promising results in a global ...

Researchers created a tool to estimate how much different drugs lower blood pressure. It may transform hypertension care by ...

Nearly half of all adults in the United States have high blood pressure, a condition known as hypertension. It is the leading ...

Net benefits of treatment were compared across categories of age, SPRINT-derived frailty status, and polypharmacy. HealthDay News — Most older adults in the Systolic Blood Pressure Intervention Trial ...

Aldosterone increases blood pressure and contributes to chronic kidney disease (CKD) progression. Trial findings suggest baxdrostat may be an effective treatment.

Compared with other measures of hypertension, the American Heart Association’s stage II hypertension category had the strongest association with disability worsening in patients with multiple ...

In patients with hypertension, renal denervation results in significant improvements in systolic blood pressure. Renal denervation (RDN) results in clinically meaningful and significantly greater ...

The trial included nearly 800 people across 214 clinics worldwide. All participants had either uncontrolled or resistant ...